Mesenchymal Stem Cells-based Cell-free Therapy Targeting Neuroinflammation

Area of Science:

• Neuroscience
• Immunology
• Regenerative Medicine

Background:

• Neuroinflammation is a key factor in neurodegenerative diseases (NDDs).
• Peripheral inflammation precedes symptomatic NDD onset and interacts with neuroinflammation.
• Microglia and astrocytes are principal cell types involved in neuroinflammation.

Purpose of the Study:

• To review recent advances in understanding neuroinflammation in NDDs.
• To highlight the role of peripheral inflammation and its interplay with neuroinflammation.
• To introduce mesenchymal stem cell-based cell-free therapy as a potential treatment for NDDs.

Main Methods:

• Review of research data predominantly from the past three years.
• Focus on genetic elements and biochemical mechanisms of neuroinflammation.
• Examination of mesenchymal stem cell-based cell-free therapy strategies.

Main Results:

• Mesenchymal stem cell-based therapy can regulate microglia and astrocytes.
• This therapy modulates peripheral nerve cell inflammation and offers targeted anti-inflammatory interventions.
• The approach focuses on superior penetration and targeted delivery for NDDs.

Conclusions:

• Mesenchymal stem cell-based cell-free therapy shows promise for managing neuroinflammation in NDDs.
• This therapy offers a novel strategy for modulating immune responses across the peripheral and nervous systems.
• Further research into engineering and safety considerations is warranted.